razormd

3 Positives From Vanda's Conference Call

That's the same CC "doublespeak" that every biotech firm uses...if Novartis and Titan didn't want iloperidone then why on earth do you think ANYONE else would?...why would anyone want to partner VEC-162 when it is basically NOTHING more than the already approved ramelteon?...pull your head out of your deluded MBA butt long enough to read the history of those two drugs...NO ONE is going to want to partner with VNDA!...of course, management won't say that until AFTER they have collected as many options as possible and AFTER they have sold as much stock as possible!...have you noticed that the CEO alone has sold about 6 MILLION bucks worth of stock in the past year?